Cargando…

Comments on validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease

To evaluate and predict liver fibrosis in patients with nonalcoholic fatty liver disease (NAFLD), several non-invasive scoring systems were built and widely used in the progress of diagnosis and treatment, which showed great diagnostic efficiency, such as aspartate aminotransferase to platelet ratio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Jian-Guo, Yan, Lun-Jie, Li, Xian, Yao, Sheng-Yu, Su, Peng, Li, Hai-Chao, Ding, Zi-Niu, Wang, Dong-Xu, Dong, Zhao-Ru, Li, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900543/ https://www.ncbi.nlm.nih.gov/pubmed/35317426 http://dx.doi.org/10.3748/wjg.v28.i6.689

Ejemplares similares

Validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease
por: Wu, Yin-Lian, et al.
Publicado: (2021)

Validation of Non-invasive Fibrosis Scores for Predicting Advanced Fibrosis in Metabolic-associated Fatty Liver Disease
por: Chen, Xiaoning, et al.
Publicado: (2022)

Comments to Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: An Enhanced Model of BARD Score
por: Guan, Yong-Song
Publicado: (2014)

Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease
por: Prasoppokakorn, Thaninee, et al.
Publicado: (2022)

Comments on the Draft Convention
por: European Council for Nuclear Research
Publicado: (1952)

Comments on the Draft Convention
por: European Council for Nuclear Research
Publicado: (1952)

Comments on the Draft Convention
por: European Council for Nuclear Research
Publicado: (1952)

Comment on: Validation of the Liver Transplant Risk Score in Europe
por: Suresan, Srutti, et al.
Publicado: (2022)

Performance of non-invasive fibrosis scores in non-alcoholic fatty liver disease with and without morbid obesity
por: Drolz, Andreas, et al.
Publicado: (2021)

Efficacy and Safety of Aspirin for Prevention of Hepatocellular Carcinoma: An Updated Meta-analysis
por: Yan, Lun-Jie, et al.
Publicado: (2022)

The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease
por: Cichoż-Lach, Halina, et al.
Publicado: (2012)

Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: An Enhanced Model of BARD Score
por: Lee, Tae Hoon, et al.
Publicado: (2013)

Development and validation of a non-invasive model for predicting significant fibrosis based on patients with nonalcoholic fatty liver disease in the United States
por: Guo, Yuanhui, et al.
Publicado: (2023)

Comment on “Advanced Hepatic Fibrosis in Fatty Liver Disease Linked to Hyperplastic Colonic Polyp”
por: Ribaldone, Davide Giuseppe, et al.
Publicado: (2017)

Comparison of a minimally invasive osteosynthesis technique with conventional open surgery for transverse patellar fractures
por: Yao, Li-Wei, et al.
Publicado: (2023)

The Prognostic Value of Natural Killer Cells and Their Receptors/Ligands in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Xue, Jun-Shuai, et al.
Publicado: (2022)

A model based on adipose and muscle-related indicators evaluated by CT images for predicting microvascular invasion in HCC patients
por: Mao, Xin-Cheng, et al.
Publicado: (2023)

Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease
por: Park, Huiyul, et al.
Publicado: (2023)

Comments on “Impact of type of procedure and surgeon on EuroSCORE operative risk validation”
por: Spiliopoulos, Kyriakos, et al.
Publicado: (2014)

Reappraisal of fibrosis-4 index and non-alcoholic fatty liver disease fibrosis score for advanced fibrosis in average-risk population
por: Park, Huiyul, et al.
Publicado: (2022)

Comment on: Conventional immunosuppression: the search for scientific evidence
por: Gandhi, Jagdeep Singh
Publicado: (2020)

Influence of Ethnicity on the Accuracy of Non-Invasive Scores Predicting Non-Alcoholic Fatty Liver Disease
por: Xia, Ming-Feng, et al.
Publicado: (2016)

Non-invasive methods to evaluate liver fibrosis in patients with non-alcoholic fatty liver disease
por: Wang, Jincheng, et al.
Publicado: (2022)

Non-invasive fibrosis assessment in non-alcoholic fatty liver disease
por: Rios, Rafael S., et al.
Publicado: (2020)

Non-invasive Liver Fibrosis Scores Are Associated With Recurrence of Postoperative Chronic Subdural Hematoma
por: Zhang, Peng, et al.
Publicado: (2022)

Validity of premature ejaculation diagnostic tool and its association with International Index of Erectile Function-15 in Chinese men with evidence-based-defined premature ejaculation
por: Tang, Dong-Dong, et al.
Publicado: (2018)

Effect of all-trans retinoic acid on casein and fatty acid synthesis in MAC-T cells
por: Liao, Xian-Dong, et al.
Publicado: (2020)

Propensity-score matched comparison between minimally invasive and conventional aortic valve replacement
por: Gašparović, Hrvoje, et al.
Publicado: (2022)

The Development of the Pediatric NAFLD Fibrosis Score (PNFS) to Predict the Presence of Advanced Fibrosis in Children with Nonalcoholic Fatty Liver Disease
por: Alkhouri, Naim, et al.
Publicado: (2014)

Liver Fibrosis Conventional and Molecular Imaging Diagnosis Update
por: Li, Shujing, et al.
Publicado: (2019)

Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
por: Basheer, Maamon, et al.
Publicado: (2023)

Incidence of venous thromboembolism after surgery for adenocarcinoma in situ and the validity of the modified Caprini score: A propensity score-matched study
por: Cai, Yong-sheng, et al.
Publicado: (2022)

Comment on Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults
por: Scholand, Mary Beth, et al.
Publicado: (2022)

Non-invasive markers of liver fibrosis in fatty liver disease are unreliable in people of South Asian descent
por: De Silva, Sampath, et al.
Publicado: (2018)

Association of blood pressure level with nonalcoholic fatty liver disease in nonhypertensive population: Normal is not the new normal
por: Qian, Lin-Yan, et al.
Publicado: (2016)

The role of non-invasive scores in determining the liver fibrosis in NAFLD and psoriatic patients
por: Neagoe, Carmen-Daniela, et al.
Publicado: (2020)

The Steatosis-associated fibrosis estimator (SAFE) score: validation in the general US population
por: van Kleef, Laurens A., et al.
Publicado: (2023)

Free fatty acids profile among lean, overweight and obese non-alcoholic fatty liver disease patients: a case – control study
por: Feng, Rennan, et al.
Publicado: (2017)

Investigation of Lonicera japonica Flos against Nonalcoholic Fatty Liver Disease Using Network Integration and Experimental Validation
por: Sun, Chun-Yong, et al.
Publicado: (2022)

Revision of the CERN Convention - Comments from the French Legal Adviser
Publicado: (1967)

Cannot write session to /tmp/vufind_sessions/sess_gmjkpeic41tii19h7ml2t3i3tr